Last updated: 24 July 2019 at 2:40am EST

Wesley Day Net Worth




The estimated Net Worth of Wesley Day is at least $553 Thousand dollars as of 1 July 2015. Wesley Day owns over 7,881 units of VIVUS stock worth over $22,914 and over the last 19 years Wesley sold VVUS stock worth over $529,644.

Wesley Day VVUS stock SEC Form 4 insiders trading

Wesley has made over 7 trades of the VIVUS stock since 2006, according to the Form 4 filled with the SEC. Most recently Wesley sold 7,881 units of VVUS stock worth $18,284 on 1 July 2015.

The largest trade Wesley's ever made was exercising 79,958 units of VIVUS stock on 23 February 2012 worth over $330,227. On average, Wesley trades about 6,252 units every 131 days since 2005. As of 1 July 2015 Wesley still owns at least 49,118 units of VIVUS stock.

You can see the complete history of Wesley Day stock trades at the bottom of the page.



What's Wesley Day's mailing address?

Wesley's mailing address filed with the SEC is 1172 CASTRO STREET, , MOUNTAIN VIEW, CA, 94040.

Insiders trading at VIVUS

Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner, and Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.



What does VIVUS do?

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.



Complete history of Wesley Day stock trades at VIVUS

Insider
Trans.
Transaction
Total value
Wesley Day
Vice President and Clinical
Sale $18,284
1 Jul 2015
Wesley Day
Vice President and Clinical
Sale $1,312
29 Jan 2015
Wesley Day
Vice President and Clinical
Sale $510,048
18 Jul 2012
Wesley Day
Vice President and Clinical
Option $330,227
23 Feb 2012
Wesley Day
Vice President and Clinical
Option $98,400
9 Jan 2012
Wesley Day
Vice President and Clinical
Option $76,421
11 Nov 2011
Wesley Day
Vice President and Clinical
Buy $13,600
2 Mar 2006


VIVUS executives and stock owners

VIVUS executives and other stock owners filed with the SEC include: